294 related articles for article (PubMed ID: 38671354)
1. Circular RNA regulatory role in pathological cardiac remodelling.
Bibi A; Bartekova M; Gandhi S; Greco S; Madè A; Sarkar M; Stopa V; Tastsoglou S; de Gonzalo-Calvo D; Devaux Y; Emanueli C; Hatzigeorgiou AG; Nossent AY; Zhou Z; Martelli F;
Br J Pharmacol; 2024 Jun; ():. PubMed ID: 38830749
[TBL] [Abstract][Full Text] [Related]
2. Nanomaterials in crossroad of autophagy control in human cancers: Amplification of cell death mechanisms.
Zhao G; Wang Y; Fan Z; Xiong J; Ertas YN; Ashammakhi N; Wang J; Ma T
Cancer Lett; 2024 Jun; 591():216860. PubMed ID: 38583650
[TBL] [Abstract][Full Text] [Related]
3. Autophagy-related ncRNAs: Regulatory Roles and Potential Therapeutic Effects in Digestive System Neoplasms.
Wei L; Wu S; Lei X; Yang X
Curr Med Chem; 2024 May; ():. PubMed ID: 38779726
[TBL] [Abstract][Full Text] [Related]
4. Hallmarks of cancer resistance.
Tufail M; Hu JJ; Liang J; He CY; Wan WD; Huang YQ; Jiang CH; Wu H; Li N
iScience; 2024 Jun; 27(6):109979. PubMed ID: 38832007
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the impact of circRNA-mediated autophagy on tumor therapeutic resistance: a novel perspective.
Wang T; He M; Zhang X; Guo Z; Wang P; Long F
Cell Mol Biol Lett; 2024 Apr; 29(1):60. PubMed ID: 38671354
[TBL] [Abstract][Full Text] [Related]
6. The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications.
Ma Y; Wang T; Zhang X; Wang P; Long F
Cell Death Dis; 2024 May; 15(5):312. PubMed ID: 38697964
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of circular RNAs and autophagy-related miRNAs in the diagnosis and treatment of pancreatic cancer.
Jiang PC; Bu SR
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):511-516. PubMed ID: 31610988
[TBL] [Abstract][Full Text] [Related]
8. CircRNAs in cancer therapy tolerance.
He M; Pan Y; You C; Gao H
Clin Chim Acta; 2024 May; 558():119684. PubMed ID: 38649011
[TBL] [Abstract][Full Text] [Related]
9. circRNAs in drug resistance of breast cancer.
Misir S; Yaman SO; Petrović N; Sumer C; Hepokur C; Aliyazicioglu Y
Oncol Res; 2022; 30(4):157-172. PubMed ID: 37304411
[TBL] [Abstract][Full Text] [Related]
10. CircPAN3 contributes to drug resistance in acute myeloid leukemia through regulation of autophagy.
Shang J; Chen WM; Liu S; Wang ZH; Wei TN; Chen ZZ; Wu WB
Leuk Res; 2019 Oct; 85():106198. PubMed ID: 31401408
[TBL] [Abstract][Full Text] [Related]
11. CircMAST1 inhibits cervical cancer progression by hindering the N4-acetylcytidine modification of YAP mRNA.
Zhang C; Yuan L; Zou Q; Shao C; Jia Y; Li J; Liao Y; Zhao X; Wen W; Jing X; Yang G; Wang W; Jiang H; Yao S
Cell Mol Biol Lett; 2024 Feb; 29(1):25. PubMed ID: 38331765
[TBL] [Abstract][Full Text] [Related]
12. Circ_0026123 promotes cisplatin resistance and progression of ovarian cancer by upregulating RAB1A through sequestering miR-543.
Wei L; He W; Zhao H; Zhao P
Anticancer Drugs; 2022 Nov; 33(10):1069-1080. PubMed ID: 36255068
[TBL] [Abstract][Full Text] [Related]
13. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression.
Li Y; Ma Z; Luo M; Liang R
Anticancer Drugs; 2022 Nov; 33(10):1024-1034. PubMed ID: 36206095
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
